Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-002309
Filing Date
2025-01-29
Accepted
2025-01-29 20:33:11
Documents
1
Period of Report
2025-01-27

Document Format Files

Seq Description Document Type Size
1 form4-01302025_010108.html 4  
1 form4-01302025_010108.xml 4 4059
  Complete submission text file 0001415889-25-002309.txt   5558
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Issuer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 784 MEMORIAL DR. CAMBRIDGE MA 02139
Business Address
Agresta Samuel (Reporting) CIK: 0001748961 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40315 | Film No.: 25570791